Complications of Iron Infusion

The Kidney International guidelines recommend mandatory 60-minute post-infusion monitoring and immediate access to resuscitation equipment for patients receiving iron infusion, due to the risk of acute hypersensitivity reactions, hypotension, and potential thrombotic complications 1, 2
All IV iron formulations carry a risk of anaphylactoid reactions, though exceedingly rare (<1:250,000 administrations), which can be life-threatening 3
Iron dextran (especially high molecular weight formulations) carries a higher risk of anaphylactoid reactions than non-dextran preparations (iron sucrose, ferric gluconate, ferric carboxymaltose) 4, 5, 6
Hypotension can occur from rapid infusion rates or "oversaturation" of transferrin with labile free iron, and slowing infusion rate is critical to prevent this 7, 8
Arthralgias and myalgias are dose-dependent, rarely occurring with doses ≤100mg but affecting up to 59% with total dose infusions 7, 8
Infusion-related adverse events occurred in 4.3% of patients in clinical trials 4, 5

Chronic and Long-Term Complications

Iron supplementation above ferritin >500 ng/mL is not recommended and potentially harmful, according to Clinical Nutrition guidelines 3
Organ damage from iron overload requires dramatically higher ferritin levels (>800-1000 ng/mL) and >20g excess iron—amounts rarely reached in dialysis patients 9, 5
Balance benefits against unknown long-term risks including infections, cardiovascular events, and death, as recommended by Kidney International guidelines 1, 10, 5
Chronic inflammation and iron therapy remain concerns for infection risk, though large randomized trials with clinical outcomes are lacking 9, 5

Verify iron deficiency with TSAT ≤30% and ferritin ≤500 ng/mL before administering iron infusion, as recommended by Kidney International guidelines 1, 2
Exclude active infection before iron therapy, according to Kidney International guidelines 1, 2
Use non-dextran formulations (iron sucrose, ferric gluconate) preferentially over iron dextran to minimize anaphylactoid risk, as recommended by Kidney International Supplements guidelines 4, 5, 6
Observe for minimum 60 minutes post-infusion with resuscitation equipment and medications immediately available, as recommended by Kidney International guidelines 1, 2